Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Eli Lilly
(NY:
LLY
)
905.38
-3.66 (-0.40%)
Official Closing Price
Updated: 7:00 PM EDT, Jun 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Eli Lilly
< Previous
1
2
...
16
17
18
19
20
21
22
23
24
...
85
86
Next >
Warren Buffett's Berkshire Hathaway, Elon Musk's Tesla And Eli Lilly Could Be Next Trillion-Dollar Companies After Nvidia's Rapid Ascension: Jim Cramer
February 26, 2024
CNBC's Jim Cramer has identified three companies that could potentially join the trillion-dollar club, in the wake of Nvidia rapid ascension.
Via
Benzinga
Future Juggernauts: The Next 7 Trillion Dollar Companies to Buy Now
February 26, 2024
The seven companies discussed here have every chance of becoming the next trillion dollar stocks for investors.
Via
InvestorPlace
Amgen's Upcoming Catalysts In 2024 Set To Unlock Multi-Billion Dollar Markets, Says Goldman Sachs
February 26, 2024
Amgen's growth outlook in 2024, with updates on key programs and upcoming catalysts. Goldman Sachs sees significant opportunities despite exclusivity losses. Dive into potential market moves and...
Via
Benzinga
Eli Lilly, Novo Nordisk's Strategies Against New Weight-Loss Drug Competitors
February 26, 2024
Zealand Pharma's drug showed positive results in 83% of patients in Phase 2 trials for MASH, heating up the race for new obesity drugs and pushing the company's shares 30% higher.
Via
Benzinga
Harvard Business Professor on Failing Well
February 24, 2024
Why would Eli Lilly put on a failure party?
Via
The Motley Fool
Assessing Eli Lilly and Co's Performance Against Competitors In Pharmaceuticals Industry
February 23, 2024
Via
Benzinga
What the Options Market Tells Us About Eli Lilly and Co
February 23, 2024
Via
Benzinga
3 Top Pharma Stocks for Investors Betting on a Biotech Boom
February 26, 2024
Pharma stocks offer phenomenal returns when their drug gets approved. Here are three stocks that could soar in 2024.
Via
InvestorPlace
Biotech Stocks Madrigal, Altimmune In A Tizzy As New Weight-Loss Rival Enters The Arena
February 26, 2024
The results from Boehringer Ingelheim and Zealand Pharma bolstered some biotech stocks. But not all got the same boost.
Via
Investor's Business Daily
This Warren Buffett Stock Is On The Cusp Of Joining The $1 Trillion Club
February 26, 2024
Berkshire Hathaway is just below a $1 trillion market cap.
Via
Investor's Business Daily
3 Highly Rated Biotech Stocks to Buy for 300% Gains
February 26, 2024
Biotech stocks like those discussed here have the potential to produce 300% returns and benefit from high analyst ratings.
Via
InvestorPlace
DexCom: A Winner In Diabetes Management
February 25, 2024
Diabetes management and glucose monitoring solutions provider DexCom, Inc. recently released its fourth-quarter results, reporting $1.0 billion in revenue, up 27% year-over-year compared to $820...
Via
Talk Markets
Could Eli Lilly Stock Help You Become a Millionaire?
February 23, 2024
Shares of Eli Lilly have risen by roughly 1,190% over the past 10 years.
Via
The Motley Fool
Eli Lilly Unusual Options Activity
February 21, 2024
Via
Benzinga
Is Eli Lilly Stock Going to $950? 1 Wall Street Analyst Thinks So.
February 24, 2024
The price tag may seem high already, but it might be just the start.
Via
The Motley Fool
3 Dividend Stocks That Are No-Brainer Buys Right Now
February 24, 2024
These stocks check off multiple boxes for investors.
Via
The Motley Fool
Obesity Solutions Like Weight Loss Drugs To Act As Catalyst For Economic Surge, Goldman Sachs Forecasts
February 23, 2024
Goldman Sachs predicts a potential 1% GDP boost from GLP-1 agonists market. Novo Nordisk and Eli Lilly lead, with analysts foreseeing 10-70 million users by 2028. AI-powered drug discovery and...
Via
Benzinga
Weight-Loss Drugs Have One Big Problem. These Drugmakers Are Taking It On.
February 23, 2024
Weight-loss drugs from Novo Nordisk and Eli Lilly lead to massive weight loss. But not all of that weight loss is healthy.
Via
Investor's Business Daily
Here's 1 Pharmaceutical Stock That Looks Unstoppable. Hint: It's Not Novo Nordisk.
February 22, 2024
Eli Lilly is home to many blockbuster drugs including Mounjaro, Jardiance, Zepbound, and more.
Via
The Motley Fool
MAIA Biotechnology: Undervalued With Eye-Popping Cancer Data And Partnership Potential
February 22, 2024
MAIA Biotechnology, a biotechnology company developing innovative cancer treatments, has seen its stock drift downwards for the past months.
Via
Talk Markets
Why Eli Lilly Stock Was Feeling Sickly on Wednesday
February 21, 2024
The company's surging popularity has made it expensive in terms of valuation.
Via
The Motley Fool
Wall Street Favorites: 7 Growth Stocks With Strong Buy Ratings for February 2024
February 21, 2024
Here are just a few of the top growth stocks investors may want to seriously consider as we get deeper into the new year.
Via
InvestorPlace
3 Stocks With the Potential to Knock Tesla Out of the Magnificent 7
February 21, 2024
These stocks are best positioned to usurp Tesla's position within Magnificent 7 stocks as it slumps further in February.
Via
InvestorPlace
Health Care Becomes Most Overweighted Sector As Hedge Funds Crowd Into Magnificent 7
February 21, 2024
Goldman Sachs' Hedge Fund Trend Monitor highlights concentration in mega-caps, with optimism in AI and health care.
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Eli Lilly Has More Than an Ozempic Competitor -- Much More
February 21, 2024
Eli Lilly's hottest treatment might be Mounjaro, but the company has a lot more at its disposal.
Via
The Motley Fool
Abbott Laboratories Stock Gets A Healthy Technical Rating Upgrade
February 21, 2024
In a welcome move, Abbott Laboratories stock saw its Relative Strength Rating improve from 67 to 73 on Wednesday.
Via
Investor's Business Daily
3 Top Sectors Investment Dollars Are Pouring Into Now: February 2024
February 20, 2024
Predicting top sectors isn't easy; we usually identify them only in hindsight, but these three stock market segments are rapidly rising.
Via
InvestorPlace
3 Cheap Dividend Stocks to Snatch Up Now
February 20, 2024
Cheap dividend stocks offer rebound upside paired with an income source that is difficult to beat for most investors.
Via
InvestorPlace
Top 7 Contenders to Join the Trillion-Dollar Club
February 20, 2024
Microsoft's ascent to the $3 trillion mark highlights the growing influence of trillion-dollar companies in the stock market.
Via
InvestorPlace
Eli Lilly & Company Should Continue Bullish Rally
February 20, 2024
Eli Lilly & Company discovers, develops & markets human pharmaceuticals worldwide. It is having around 742 B$ market cap as of 16 February 2024.
Via
Talk Markets
< Previous
1
2
...
16
17
18
19
20
21
22
23
24
...
85
86
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.